Nexesta Fe Kit
Product Images NDC 65862-926

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nexesta Fe (NDC 65862-926). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Norethindroneethinyl Fig1)

This appears to be a list of studies related to contraceptive use among women. Some studies are mentioned by name and year, and their use of contraception is noted either as "ever use" or "current use." However, there is also some garbled text and numbers that are not readable.*

FDA Label Image

Figure A (Norethindroneethinyl Fig2)

This text is providing information about different types of birth control methods and their effectiveness. The number of pregnancies per 100 women in one year is shown for each method, ranging from fewer than one to 85 or more. The different birth control methods are categorized as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during the most fertile days of the monthly cycle, spermicide, withdrawal, and no birth control.*

FDA Label Image

Figure3 (Norethindroneethinyl Fig3)

Nexesta Fe is a combination of norethindrone and ethinyl estradiol tablets along with ferrous fumarate tablets. The tablet is chewable and available in multiple strengths of 0.4mg and 0.035mg. The tablets are divided into four weeks for an entire cycle with Week 4 being inactive. Figure A is also available with an unclear representation.*

FDA Label Image

Package Label-principal Display Panel (0.4 mg/0.035 mg Pouch Label)

FDA Label Image

Package Label-principal Display Panel (0.4 mg/0.035 mg Blister Carton)

This is a description of a pharmaceutical product called "NexestaTM Fe". Each package of NexestaTM Fe contains 21 white to off-white tablets which contain norethindrone USP 0.4 mg and ethinyl estradiol USP 0.035 mg, and 7 brown tablets which contain ferrous fumarate USP 75 mg. This product is intended to prevent pregnancy but does not protect against HIV or other sexually transmitted diseases. The package contains one blister pack of 28 tablets, and for adverse reactions contact Aurobindo Pharma USA, Inc.*

FDA Label Image

Norethindroneethinyl Fig6

This appears to be the packaging information for Exesta Fe, which is a prescription medication that contains Norethindrone and Ethinyl Estradiol, as well as Ferrous Fumarate. These chewable tablets are used to prevent pregnancy and also help with iron deficiency. The dosage is 0.4mg/0.035mg.*

FDA Label Image

Chemical Structure (Norethindroneethinyl Str1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.